Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
144 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 65438 |
45 | 2 | HEPATITIS C VIRUS//HEPATITIS C//HCV | 31075 |
652 | 1 | DIRECT ACTING ANTIVIRALS//SOFOSBUVIR//TELAPREVIR | 3225 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | DIRECT ACTING ANTIVIRALS | authKW | 1798730 | 9% | 65% | 283 |
2 | SOFOSBUVIR | authKW | 1588420 | 7% | 74% | 219 |
3 | TELAPREVIR | authKW | 1489399 | 7% | 66% | 230 |
4 | DACLATASVIR | authKW | 1105999 | 4% | 84% | 135 |
5 | SIMEPREVIR | authKW | 970300 | 4% | 83% | 120 |
6 | BOCEPREVIR | authKW | 841865 | 4% | 62% | 138 |
7 | LEDIPASVIR | authKW | 646123 | 2% | 85% | 78 |
8 | TEXAS LIVER | address | 598466 | 2% | 84% | 73 |
9 | NS5A INHIBITOR | authKW | 555836 | 2% | 89% | 64 |
10 | HEPATITIS C | authKW | 552619 | 19% | 9% | 612 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 73228 | 45% | 1% | 1436 |
2 | Virology | 10411 | 14% | 0% | 450 |
3 | Infectious Diseases | 10110 | 17% | 0% | 553 |
4 | Pharmacology & Pharmacy | 3561 | 21% | 0% | 682 |
5 | Microbiology | 1359 | 10% | 0% | 318 |
6 | Medicine, General & Internal | 1345 | 11% | 0% | 351 |
7 | Health Care Sciences & Services | 617 | 3% | 0% | 110 |
8 | Health Policy & Services | 311 | 2% | 0% | 61 |
9 | Public, Environmental & Occupational Health | 148 | 4% | 0% | 137 |
10 | Immunology | 136 | 5% | 0% | 162 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TEXAS LIVER | 598466 | 2% | 84% | 73 |
2 | BETTY GUY BEATTY INTEGRATED | 139276 | 1% | 32% | 45 |
3 | VIRAL HEPATITIS | 106110 | 3% | 11% | 99 |
4 | HEPATOL | 103306 | 8% | 4% | 260 |
5 | LIVER VIRGINIA | 71449 | 0% | 46% | 16 |
6 | KYUSHU GEN INTERNAL MED | 66989 | 0% | 57% | 12 |
7 | UNC LIVER | 65948 | 0% | 75% | 9 |
8 | LIVER DIS | 65018 | 4% | 5% | 133 |
9 | REFERENCE VIRAL HEPATITIS B C D | 60874 | 0% | 69% | 9 |
10 | GASTROENTEROL HEPATOL | 60279 | 14% | 1% | 451 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF VIRAL HEPATITIS | 111028 | 5% | 7% | 161 |
2 | LIVER INTERNATIONAL | 48616 | 4% | 4% | 115 |
3 | ANTIVIRAL THERAPY | 31477 | 2% | 4% | 79 |
4 | JOURNAL OF HEPATOLOGY | 30314 | 5% | 2% | 155 |
5 | HEPATOLOGY | 22131 | 5% | 1% | 166 |
6 | CLINICS IN LIVER DISEASE | 12492 | 1% | 5% | 25 |
7 | EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 9361 | 1% | 4% | 25 |
8 | HEPATOLOGY INTERNATIONAL | 7005 | 1% | 3% | 22 |
9 | HEPATOLOGY RESEARCH | 6100 | 1% | 2% | 42 |
10 | DIGESTIVE AND LIVER DISEASE | 5925 | 1% | 1% | 41 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIRECT ACTING ANTIVIRALS | 1798730 | 9% | 65% | 283 | Search DIRECT+ACTING+ANTIVIRALS | Search DIRECT+ACTING+ANTIVIRALS |
2 | SOFOSBUVIR | 1588420 | 7% | 74% | 219 | Search SOFOSBUVIR | Search SOFOSBUVIR |
3 | TELAPREVIR | 1489399 | 7% | 66% | 230 | Search TELAPREVIR | Search TELAPREVIR |
4 | DACLATASVIR | 1105999 | 4% | 84% | 135 | Search DACLATASVIR | Search DACLATASVIR |
5 | SIMEPREVIR | 970300 | 4% | 83% | 120 | Search SIMEPREVIR | Search SIMEPREVIR |
6 | BOCEPREVIR | 841865 | 4% | 62% | 138 | Search BOCEPREVIR | Search BOCEPREVIR |
7 | LEDIPASVIR | 646123 | 2% | 85% | 78 | Search LEDIPASVIR | Search LEDIPASVIR |
8 | NS5A INHIBITOR | 555836 | 2% | 89% | 64 | Search NS5A+INHIBITOR | Search NS5A+INHIBITOR |
9 | HEPATITIS C | 552619 | 19% | 9% | 612 | Search HEPATITIS+C | Search HEPATITIS+C |
10 | DIRECT ACTING ANTIVIRAL AGENTS | 465207 | 2% | 64% | 74 | Search DIRECT+ACTING+ANTIVIRAL+AGENTS | Search DIRECT+ACTING+ANTIVIRAL+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |